Hepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.

Purpose To determine whether variable hepatic microwave ablation (MWA) can induce local inflammation and distant pro-oncogenic effects compared with hepatic radiofrequency ablation (RFA) in an animal model. Materials and Methods In this institutional Animal Care and Use Committee-approved study, F344 rats (150 gm, n = 96) with subcutaneous R3230 breast adenocarcinoma tumors had normal non-tumor-bearing liver treated with RFA (70°C × 5 minutes), rapid higher-power MWA (20 W × 15 seconds), slower lower-power MWA (5 W × 2 minutes), or a sham procedure (needle placement without energy) and were sacrificed at 6 hours to 7 days (four time points; six animals per arm per time point). Ablation settings produced 11.4 mm ± 0.8 of coagulation for all groups. Distant tumor growth rates were determined to 7 days after treatment. Liver heat shock protein (HSP) 70 levels (at 72 hours) and macrophages (CD68 at 7 days), tumor proliferative indexes (Ki-67 and CD34 at 7 days), and serum and tissue levels of interleukin 6 (IL-6) at 6 hours, hepatocyte growth factor (HGF) at 72 hours, and vascular endothelial growth factor (VEGF) at 72 hours after ablation were assessed. All data were expressed as means ± standard deviations and were compared by using two-tailed t tests and analysis of variance for selected group comparisons. Linear regression analysis of tumor growth curves was used to determine pre- and posttreatment growth curves on a per-tumor basis. Results At 7 days, hepatic ablations with 5-W MWA and RFA increased distant tumor size compared with 20-W MWA and the sham procedure (5-W MWA: 16.3 mm ± 1.1 and RFA: 16.3 mm ± 0.9 vs sham: 13.6 mm ± 1.3, P < .01, and 20-W MWA: 14.6 mm ± 0.9, P < .05). RFA and 5-W MWA increased postablation tumor growth rates compared with the 20-W MWA and sham arms (preablation growth rates range for all arms: 0.60-0.64 mm/d; postablation: RFA: 0.91 mm/d ± 0.11, 5-W MWA: 0.91 mm/d ± 0.14, P < .01 vs pretreatment; 20-W MWA: 0.69 mm/d ± 0.07, sham: 0.56 mm/d ± 1.15; P = .48 and .65, respectively). Tumor proliferation (Ki-67 percentage) was increased for 5-W MWA (82% ± 5) and RFA (79% ± 5), followed by 20-W MWA (65% ± 2), compared with sham (49% ± 5, P < .01). Likewise, distant tumor microvascular density was greater for 5-W MWA and RFA (P < .01 vs 20-W MWA and sham). Lower-energy MWA and RFA also resulted in increased HSP 70 expression and macrophages in the periablational rim (P < .05). Last, IL-6, HGF, and VEGF elevations were seen in 5-W MWA and RFA compared with 20-W MWA and sham (P < .05). Conclusion Although hepatic MWA can incite periablational inflammation and increased distant tumor growth similar to RFA in an animal tumor model, higher-power, faster heating protocols may potentially mitigate such undesired effects. © RSNA, 2016.

[1]  G. Gravante,et al.  Renal effects of microwave ablation compared with radiofrequency, cryotherapy and surgical resection at different volumes of the liver treated , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[2]  S. Wells,et al.  Liver Ablation: Best Practice. , 2015, Radiologic clinics of North America.

[3]  Christopher L Brace,et al.  Microwave tissue ablation: biophysics, technology, and applications. , 2010, Critical reviews in biomedical engineering.

[4]  M. Gonen,et al.  Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. , 2013, Journal of vascular and interventional radiology : JVIR.

[5]  G. Gazelle,et al.  Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. , 2000, AJR. American journal of roentgenology.

[6]  G. Gravante,et al.  Changes in interleukin-1β and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. , 2010, American journal of surgery.

[7]  M. Dewhirst,et al.  Radiofrequency ablation: The effect of distance and baseline temperature on thermal dose required for coagulation , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[8]  Philippe L. Pereira,et al.  Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. , 2013, Radiology.

[9]  S. Goldberg,et al.  Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model. , 2016, Radiology.

[10]  S. Goldberg,et al.  Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy , 2015, PloS one.

[11]  Sahil Mittal,et al.  Epidemiology of hepatocellular carcinoma: consider the population. , 2013, Journal of clinical gastroenterology.

[12]  Luigi Solbiati,et al.  Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. , 2012, Radiology.

[13]  L. Schwartz,et al.  Ki-67 is a Prognostic Biomarker of Survival after Radiofrequency Ablation of Liver Malignancies , 2012, Annals of Surgical Oncology.

[14]  H. Kalthoff,et al.  Profile of serum factors and disseminated tumor cells before and after radiofrequency ablation compared to resection of colorectal liver metastases - a pilot study. , 2015, Anticancer research.

[15]  T. Livraghi,et al.  Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. , 2009, Radiology.

[16]  C. Christophi,et al.  Altered growth patterns of colorectal liver metastases after thermal ablation. , 2006, Surgery.

[17]  S. Kaneko,et al.  In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation , 2014, Cancer Immunology, Immunotherapy.

[18]  C. Christophi,et al.  Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met , 2013, Clinical & Experimental Metastasis.

[19]  P. Ziakas,et al.  Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. , 2015, World journal of hepatology.

[20]  S. Goldberg,et al.  Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation. , 2015, Radiology.

[21]  J. Bosch,et al.  Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model. , 2012, The Journal of urology.

[22]  J. Köllermann,et al.  First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial , 2016, CardioVascular and Interventional Radiology.

[23]  S. Goldberg,et al.  Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition. , 2016, Radiology.

[24]  S. Goldberg,et al.  Radiofrequency Ablation: Inflammatory Changes in the Periablative Zone Can Induce Global Organ Effects, including Liver Regeneration. , 2015, Radiology.

[25]  S. Goldberg,et al.  Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model. , 2003, Radiology.

[26]  Karen T. Brown,et al.  Margin Size is an Independent Predictor of Local Tumor Progression After Ablation of Colon Cancer Liver Metastases , 2013, CardioVascular and Interventional Radiology.

[27]  P. V. van Diest,et al.  Accelerated Perinecrotic Outgrowth of Colorectal Liver Metastases Following Radiofrequency Ablation is a Hypoxia-Driven Phenomenon , 2009, Annals of surgery.

[28]  S. Goldberg,et al.  Thermal ablation a comparison of thermal dose required for radiofrequency-, microwave-, and laser-induced coagulation in an ex vivo bovine liver model. , 2009, Academic radiology.

[29]  R. Woodman,et al.  Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta‐analysis , 2016, Journal of gastroenterology and hepatology.

[30]  Carlo Bartolozzi,et al.  Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. , 2005, Radiology.

[31]  Jiahong Dong,et al.  Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference. , 2010, The Journal of surgical research.

[32]  Christopher L Brace,et al.  Principles of and advances in percutaneous ablation. , 2011, Radiology.